2026 Korean expert recommendations for the use of thrombopoietin receptor agonists in severe aplastic anemia. [PDF]
Park S +6 more
europepmc +1 more source
Switching patients with immune thrombocytopenia (ITP) to avatrombopag from other thrombopoietin receptor agonists: The real-world experience of the Spanish ITP Group (GEPTI). [PDF]
Pascual-Izquierdo C +39 more
europepmc +1 more source
Overuse of thrombopoietin receptor agonists driven by suboptimal response is associated with myelofibrosis in pediatric immune thrombocytopenia. [PDF]
Ma J +15 more
europepmc +1 more source
Romiplostim-N01 for cancer therapy-induced thrombocytopenia: A propensity score-matched cohort study. [PDF]
Yu T +5 more
europepmc +1 more source
Evolving Patterns of TPO-RA Use in Children: A Decade of Single-Centre Experience and Narrative Review. [PDF]
Urbański B +8 more
europepmc +1 more source
Refractory Thrombocytopenia in TP53-Aberrant Chronic Lymphocytic Leukemia: A Multimechanistic Case with Response to Idelalisib and Romiplostim. [PDF]
Guven S, Kacar H, Seker O, Demirkan F.
europepmc +1 more source
Mutational landscape of classical myeloproliferative neoplasms in the Western Cape Province, South Africa. [PDF]
Dicks MJ +4 more
europepmc +1 more source
Real-world use of thrombopoietic agents in treatment-naïve children with severe aplastic anemia: a multicenter retrospective study. [PDF]
Chazli YE +11 more
europepmc +1 more source
A case of immune thrombocytopenia complicated by catastrophic antiphospholipid antibody syndrome and subsequent intramuscular haemorrhage. [PDF]
Banerjee P +5 more
europepmc +1 more source
Personalized Management of Cytopenias in Chronic Liver Disease: From Pathophysiology to Treatment Strategies. [PDF]
Wang X, Fu S, Zhu X, Zhao Y.
europepmc +1 more source

